• Non ci sono risultati.

Coronavirus Disease 2019 (COVID-19) in Italy

N/A
N/A
Protected

Academic year: 2022

Condividi "Coronavirus Disease 2019 (COVID-19) in Italy"

Copied!
1
0
0

Testo completo

(1)

22 512

cases of COVID-19

2026

cases of COVID-19 among health care workers

1625

deaths

Coronavirus Disease 2019 (COVID-19) in Italy

Data as of March 15, 2020

Sources: Adapted from the COVID-19 Task Force of the Department of Infectious Diseases and the IT Service Instituto Superiore di Sanità. https://www.iss.it/infografiche Please cite as: JAMA. Published online March 17, 2020. doi:10.1001/jama.2020.4344 Authors: Edward Livingston, MD;

Karen Bucher, MA, CMI

Cases by age range

Cases by region/province of diagnosis Timeline of COVID-19 symptom onset and diagnosis in 2020

Cases by sex Cases by severity

Age, y 0-9 10-19 20-29 30-39 40-49 50-59 60-69 70-79 80-89

≥90 Not reported

Total

Deaths, No. (% of total) 0

0 0 4 (0.25) 10 (0.62) 43 (2.65) 139 (8.55) 578 (35.57) 694 (42.71) 156 (9.6) 1 (0.06)

1625 (100)

Case-fatality rate, % 0

0 0 0.3 0.4 1.0 3.5 12.5 19.7 22.7 0.6

7.2 37.6%

>70 y

1.2%

0-18 y

37.3%

51-70 y

24.0%

19-50 y 40.2%

Female

59.8%

Male

46.1%

Mild

24.9%

Severe

10.6%

Unspecified symptoms

6.7%

No symptoms

5.0%

Critical

6.7%

Few symptoms

Patients

Mar 9 Mar 2

Feb 24 Feb 17

Feb 10 Feb 3

Jan 28 500 1000 1500 2000

1-50 51-200 201-500 501-1000 1001-2000

>2000 Date of symptom onset (8331 cases)

Date of diagnosis/sample (13 323 cases)

Data in the shaded area should be interpreted with caution due to the possible reporting delay of more recently diagnosed cases and cases with date of onset within the reporting period that have not yet been diagnosed

Median age, 64 y

News & Analysis

JAMA Infographic

jama.com (Reprinted) JAMA Published online March 17, 2020 E1

© 2020 American Medical Association. All rights reserved.

Downloaded From: https://jamanetwork.com/ by Piergiorgio Gigliotti on 03/23/2020

Riferimenti

Documenti correlati

T he global pandemic of novel coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syn- drome coronavirus 2 (SARS-CoV-2) began in Wuhan, China, in December 2019,

The virus is thought to spread mainly between people who are in close contact with one another (within about 6 feet) through respiratory droplets produced when an infected

Your article is protected by copyright and all rights are held exclusively by Swiss School of Public Health (SSPH+). This e-offprint is for personal use only and shall not be

guidance on cancer care during the Italian SARS- CoV-2 outbreak, the Italian Association of Medical Oncology (AIOM) in partnership with the boards of Academic Oncologists (COMU)

Specialty section: This article was submitted to Public Health Policy, a section of the journal Frontiers in Public Health Received: 23 April 2020 Accepted: 07 August 2020 Published:

Ordinanza Ministero della salute e Regione Friuli Venezia Giulia 23 febbraio 2020 • Misure urgenti in materia di contenimento e gestione dell’emergenza epidemiologica

19: Coronavirus disease 2019; DNA: Deoxyribonucleic acid; ESGE: European Society for Gynecological Endoscopy; PPE: Personal protective equipment; RCOG: Royal College of Obstetrics

Interim Infection Prevention and Control Recommendations for Patients with Suspected or Confirmed Coronavirus Disease 2019 (COVID-19) in Healthcare Settings..